Piper Sandler analyst Jason Bednar reiterated an Overweight rating and $8.00 price target on MDxHealth SA (NASDAQ: MDXH).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

BTIG Reiterates Buy Rating on MDxHealth SA (MDXH)August 23, 2024 5:05 AM